Skip to content
All Updates
- National Pharmacovigilance Cell (NPC), DRAP released draft Guidelines on National Pharmacovigilance System (Edition 02) seeking comments from stakeholdersAugust 24, 2022
- DRAP and Islamia University of Bahawalpur (IUB) signed a Memorandum of Understanding (MoU) to promote scientific CollaborationAugust 19, 2022
- Training Sessions on Regulatory Data Standards for Manufacturers at Karachi and LahoreAugust 15, 2022
- Recall Alert; Drug Product: Molimax 5mg/5ml Oral Suspension (Batch # L2165) by M/s. Alliance Pharmaceuticals Pvt Ltd, PeshawarAugust 12, 2022
- Invitation to bid (For Stationery & other Miscellaneous Items)August 12, 2022
- Falsified Alert; Drug Product: Presence of falsified Glucantime (meglumine antimonate) in market purported to be manufactured by M/s. Tillotts pharma AG, SwitzerlandAugust 11, 2022
- Recall Alert; Drug Product: Sterile Water for Injection (Batch # 739 and 751) by M/s. Zafa Pharmaceutical Laboratories (Pvt) Ltd., KarachiAugust 11, 2022
- Recall Alert; Drug Product: Phenerzine Elixir (Batch # 037) by M/s Epoch Pharmaceuticals (Pvt) Ltd., KarachiAugust 2, 2022
- Recall Alert; Drug Product: Faasgablin 75mg Capsules (Batch # 2210C001) by M/s FAAS Pharmaceuticals (Pvt) Ltd., KarachiAugust 2, 2022
- Training on Pharmacovigilance Module (AEFI/PV) in the Pakistan Integrated Regulatory Information Management System (PIRIMS)July 30, 2022
- Minutes of 287th Meeting of Central Licensing Board held on 24th June 2022July 29, 2022
- Bob Tribe, TGAs former GMP Chief, assists DRAP for Strengthening of Inspection System towards harmonized PIC/s GMP StandardsJuly 28, 2022
- An interactive Session of Academia and Regulators on Healthcare Research and Collaborative RoleJuly 27, 2022
- Decisions of 48th meeting of Medial Device Board (Deficiency letters)July 27, 2022
- ISPE Singapore Conference & Exhibition 2022, 17-19 August, 2022 (Free Registration for Inspectors and Pharma Manufacturers from Pakistan)July 25, 2022
- National Essential Medicine ListsJuly 22, 2022
- National Pharmacovigilance Center Convened one-day Training Session for Clinical / Hospital Pharmacist and Pharmacovigilance Officer at Rawalpindi Medical UniversityJuly 22, 2022
- S.R.O. 1083(I)/2022 (Maximum retail price of Remdesivir injection)July 22, 2022
- Draft amendments in rules framed under Drug Act 1976 (for comments within 7 days of publication of SRO).July 21, 2022
- Policy for Inspection of Manufacturing Site AbroadJuly 6, 2022
- DRAP notified National Pharmacovigilance Centre (NPC) under the Pharmacovigilance Rules, 2022July 6, 2022
- Minutes of 317th Meeting of Registration Board held on 16th – 17th May, 2022.June 27, 2022
- Minutes of 286th Meeting of Central Licensing Board held on 11th May 2022June 24, 2022
- DRAP notified Pharmacovigilance Risk Assessment Expert Committee (PRAEC) under the Pharmacovigilance Rules, 2022June 20, 2022
- Proposed amendments in the Rules : DRAP invites comments from stakeholders and public on the draft amendments in the Drugs (Licensing, Registering and Advertising) Rules, 1976;June 20, 2022
- National Pharmacovigilance Centre, DRAP intends to seek comments of Stakeholders on “Draft Guidelines on High Alert Medication Management”June 16, 2022
- Suspension of Drug Registration: Famotidine Liquid Suspension in the Strengths of 10mg/5mL and 40mg/mLJune 16, 2022
- Suspension of Drug Registration: Tablets of Diclofenac Potassium in Strengths of 75mg and 100mgJune 16, 2022
- Recall Alert: Drug Product; Water for Injection (Batch #M21421) by M/s. Vision Pharmaceuticals (Pvt.) Ltd., Islamabad.June 15, 2022
- Decisions of 47th meeting of Medical Device Board Meeting; Deficiency letterJune 15, 2022
- DRAP Organizes one-day Training Workshop of its officers on Key Performance Indicators (KPIs) of various Regulatory FunctionsJune 14, 2022
- Voluntary Recall Alert: Drug Product; Meronem 1g Injection (Batch #4A20B27 and Batch # 4A21D29) by M/S. Pfizer Pakistan Limited, KarachiJune 2, 2022
- Partial Minutes of 317th Meeting of Registration BoardMay 31, 2022
- Deficiency Deferred Letters 104th,105th And 106th Meeting of EECMay 31, 2022
- DRAP invites comments of stakeholders on the draft Guidelines on Good Distribution Practices for Pharmaceutical and Biological ProductsMay 28, 2022
- Holding of Khuli E-KachehriMay 23, 2022
- National Pharmacovigilance Centre, DRAP holds one-day training session for Healthcare Professionals in collaboration with regional centre.May 20, 2022
- S.R.O.559(I)/2022 (Amendments in the Medical Devices Rules, 2017)May 18, 2022
- Stakeholder Comments are invited on draft guidance for Categorization of deficiencies in Good Manufacturing Practices (GMP)May 18, 2022
- DRAP issued Guidelines for Public Health Programs (PHPs) to promote Pharmacovigilance activities and enhancing collaboration with National Pharmacovigilance Centre, DRAP.May 16, 2022
- Minutes of 316th Meeting of Registration Board held on 15th to 18th March, 2022May 14, 2022
- Invitation to Bid: Purchase & Deployment of Endpoint Security / Antivirus SoftwareMay 14, 2022
- DRAP issues guidance on the submissions of Clinical Trials ApplicationsMay 12, 2022
- Minutes of 285th Meeting of Central Licensing Board held on 17-18th March 2022April 28, 2022
- DRAP issues final Guidance document for applicants on Import and Export permissions of therapeutic goods in the countryApril 27, 2022
- Mr. Asim Rauf, CEO, DRAP met with WHO Country Representative, Dr Palitha Gunarathna Mahipala to promote bilateral cooperationApril 27, 2022
- DRAP notified the Pharmacovigilance Rules, 2022, for active monitoring of safety of therapeutic goods across the countryApril 26, 2022
- National Pharmacovigilance Centre, DRAP issued draft guidelines on promoting Pharmacovigilance activities in Public Health Programs (PHPs).April 23, 2022
- Drug Product Recall: Water for Injection (Batch # 826) by M/s. Zafa Pharmaceutical Laboratories Pvt Ltd, Karachi.April 21, 2022
- DRAP issues a guidance for Healthcare Professionals on reporting of Adverse Events to the Pharmacovigilance CentersApril 15, 2022
